Table 3. Literature overview.
Authors | Year | Design | Intervention | n | IOP preOP
(mmHg) |
Success
(%) |
Vision
loss (%) |
Phthisis
bulbi (%) |
---|---|---|---|---|---|---|---|---|
Mermoud et al. 60 | 1993 | retrospective | Molteno-Valve | 60 | 42.3 ± 13.2 | 62 | 48 | 18 |
Every et al. 49 | 2006 | prospective | Molteno-Valve | 145 | 40.1 ± 13.0 | 72 | 32 | N/A |
Yalvac et al. 8, 48 | 2007 | retrospective | Ahmed-Valve vs Molteno-
Valve |
38/27 | 39.5 ± 4.5 vs
39.3 ± 3.9 |
63 vs 37 | 23-33 | 7.9-14.8 |
Takihara et al. 56 | 2009 | retrospective | Trabeculectomy + MMC | 101 | 35.9 ± 11.3 | 62.6 | 12.9 | 5.0 |
Netland et al. 51 | 2010 | retrospective | Ahmed-Valve ± NVG | 38/38 | 39.1 ± 11.2 vs
43.8 ± 11.0 |
89.2 vs
73.1 |
23,7 | 13,2 |
Shen et al. 61 | 2011 | retrospective | Trabeculectomy versus
Ahmed-Valve |
20/20 | 47.7 ± 10.2 vs
47.8 ± 11.3 |
70 vs 65 | 15 vs 30 | 5.0 |
Xie et al. 50 | 2019 | retrospective | Ahmed-Valve | 66 | 48.23±8.17 | 66.7 | N/A | N/A |
Strzalkowski et al. 37 | 2021 | retrospective | PPV+EL+Avastin+ CPC | 77 | 46.0 ± 10.3 | 64.6 | 3.9 | 5.7 |